Inactive Instrument
CannaVEST Corp Stock Other OTC
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-14 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.9M 4.28M 3.93M 3.67M 6.95M 466M 7.05M 47.21M 18.35M 229M 18.38M 17.98M 790M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.61M 5.78M 5.31M 4.96M 9.39M 630M 9.53M 63.78M 24.79M 309M 24.83M 24.29M 1.07B | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | ||
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | ||
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | ||
| +3.86% | +1.85% | +31.30% | +24.86% | 339B | ||
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | ||
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | ||
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | ||
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | ||
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | ||
| Average | +2.10% | +4.92% | +31.10% | +56.12% | 411.08B | |
| Weighted average by Cap. | +2.24% | +5.54% | +41.79% | +80.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.74M 12.61M 11.77M 22.3M 1.5B 22.63M 151M 58.87M 734M 58.96M 57.68M 2.53B | 13.79M 12.06M 11.07M 10.33M 19.58M 1.31B 19.87M 133M 51.69M 645M 51.77M 50.64M 2.22B |
| Net income | -2.39M -2.09M -1.92M -1.79M -3.4M -228M -3.45M -23.09M -8.97M -112M -8.99M -8.79M -386M | -958K -838K -769K -718K -1.36M -91.2M -1.38M -9.24M -3.59M -44.79M -3.6M -3.52M -155M |
| Net Debt | 325K 284K 261K 244K 461K 30.94M 468K 3.13M 1.22M 15.19M 1.22M 1.19M 52.43M | 1.72M 1.5M 1.38M 1.29M 2.44M 164M 2.48M 16.57M 6.44M 80.32M 6.45M 6.31M 277M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















